This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Sep 1;370(9589):735; author reply 736-7.

doi: 10.1016/S0140-6736(07)61364-6.

Prevention of venous thromboembolism after acute ischaemic stroke

Marcelo J Melero, Bernardo Bergroth, Damián M Contardo, Mariano M Mazzei

PMID: 17765510
DOI: 10.1016/S0140-6736(07)61364-6

Comment

Prevention of venous thromboembolism after acute ischaemic stroke

Marcelo J Melero et al. Lancet. 2007.

. 2007 Sep 1;370(9589):735; author reply 736-7.

doi: 10.1016/S0140-6736(07)61364-6.

Authors

Marcelo J Melero, Bernardo Bergroth, Damián M Contardo, Mariano M Mazzei

PMID: 17765510
DOI: 10.1016/S0140-6736(07)61364-6

No abstract available

PubMed Disclaimer

Comment on

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.
Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, O'Riordan W, Pineo GF; PREVAIL Investigators. Sherman DG, et al. Lancet. 2007 Apr 21;369(9570):1347-1355. doi: 10.1016/S0140-6736(07)60633-3. Lancet. 2007. PMID: 17448820 Clinical Trial.

Similar articles

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.
Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, O'Riordan W, Pineo GF; PREVAIL Investigators. Sherman DG, et al. Lancet. 2007 Apr 21;369(9570):1347-1355. doi: 10.1016/S0140-6736(07)60633-3. Lancet. 2007. PMID: 17448820 Clinical Trial.
Prevention of venous thromboembolism after acute ischaemic stroke.
Ricci S, Celani MG, Righetti E, Dennis M, Sandercock P. Ricci S, et al. Lancet. 2007 Sep 1;370(9589):735-6; author reply 736-7. doi: 10.1016/S0140-6736(07)61365-8. Lancet. 2007. PMID: 17765511 No abstract available.
Prevention of venous thromboembolism after acute ischaemic stroke.
Martins HS, Scalabrini-Neto A, Velasco IT. Martins HS, et al. Lancet. 2007 Sep 1;370(9589):736; author reply 736-7. doi: 10.1016/S0140-6736(07)61366-X. Lancet. 2007. PMID: 17765513 No abstract available.
Low-molecular-weight heparins are essentially the same for treatment and prevention of venous thromboembolism.
Lopez LM. Lopez LM. Pharmacotherapy. 2001 Jun;21(6 Pt 2):56S-61S; discussion 71S-72S. doi: 10.1592/phco.21.8.56s.34596. Pharmacotherapy. 2001. PMID: 11401194 Review.
Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
Haas S. Haas S. Semin Thromb Hemost. 1999;25 Suppl 3:101-5. Semin Thromb Hemost. 1999. PMID: 10549724 Review.

See all similar articles

Cited by

Anticoagulants for acute ischaemic stroke.
Wang X, Ouyang M, Yang J, Song L, Yang M, Anderson CS. Wang X, et al. Cochrane Database Syst Rev. 2021 Oct 22;10(10):CD000024. doi: 10.1002/14651858.CD000024.pub5. Cochrane Database Syst Rev. 2021. PMID: 34676532 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information